Monsalve D, Acosta-Ampudia Y, Acosta N, Celis-Andrade M, Sahin A, Yilmaz A
J Transl Autoimmun. 2025; 10:100280.
PMID: 40071133
PMC: 11894324.
DOI: 10.1016/j.jtauto.2025.100280.
Diaz M, Mikulski Z, Leaman D, Gandarilla A, Da Silva N, Verkoczy A
Front Immunol. 2025; 16:1488388.
PMID: 40070822
PMC: 11893414.
DOI: 10.3389/fimmu.2025.1488388.
Karabey M, Kaya H, Ceylan A, Kaba K, Ozdemir M, Feyzioglu B
Arch Rheumatol. 2025; 39(4):541-548.
PMID: 40060139
PMC: 11883259.
DOI: 10.46497/ArchRheumatol.2024.10330.
Zlatkovic-Svenda M, Rasic M, Ovuka M, Pavlov-Dolijanovic S, Atanaskovic Popovic M, Ogric M
Biomedicines. 2025; 13(2).
PMID: 40002929
PMC: 11852539.
DOI: 10.3390/biomedicines13020516.
Xie A, Liu Z, Wang S, Yuan M, Xie L, Liu S
Immun Inflamm Dis. 2025; 13(2):e70158.
PMID: 39945244
PMC: 11822662.
DOI: 10.1002/iid3.70158.
Antiphospholipid Antibodies and COVID-19: A Systematic Review of Clinical Implications.
Sabaghian T, Kharazmi A, Omidi F, Hajikhani B, Tehrani S, Mardani S
Immun Inflamm Dis. 2025; 13(2):e70134.
PMID: 39898621
PMC: 11789270.
DOI: 10.1002/iid3.70134.
Autoantibodies in COVID-19: implications for disease severity and clinical outcomes.
Galipeau Y, Cooper C, Langlois M
Front Immunol. 2025; 15():1509289.
PMID: 39835117
PMC: 11743527.
DOI: 10.3389/fimmu.2024.1509289.
Autoantibodies in hospitalised patients with COVID-19.
Tiniakou E, Casciola-Rosen L, Thomas M, Manabe Y, Antar A, Damarla M
Clin Transl Immunology. 2024; 13(12):e70019.
PMID: 39734590
PMC: 11671454.
DOI: 10.1002/cti2.70019.
Prothrombotic Antibodies Targeting the Spike Protein's Receptor-Binding Domain in Severe COVID-19.
Zhu W, Zheng Y, Yu M, Witman N, Zhou L, Wei J
Blood. 2024; .
PMID: 39576992
PMC: 11811936.
DOI: 10.1182/blood.2024025010.
Inflammation, immunity and biomarkers in procoagulant responses of critically ill patients.
Lian H, Cai H, Zhang H, Zhang Y, Wang X
Am J Transl Res. 2024; 16(10):5797-5812.
PMID: 39544782
PMC: 11558399.
DOI: 10.62347/EDAR9565.
Postoperative multiple perforations of the small bowel in a patient with COVID-19 - case report.
Dumitrescu T, Mesina C, Ciorbagiu M, Lascu L, Hontaru S, Ionovici N
Rom J Morphol Embryol. 2024; 65(3):531-535.
PMID: 39529347
PMC: 11657326.
DOI: 10.47162/RJME.65.3.16.
The well-defined antiphospholipid syndrome induced by COVID-19: a rare case report and review of the literature.
Ren Z, Xiong R, Wang L, Chen Z, Chen R, Liu Z
Thromb J. 2024; 22(1):99.
PMID: 39516860
PMC: 11549801.
DOI: 10.1186/s12959-024-00669-6.
Arterial floating mural thrombi are a characteristic imaging pattern in SARS-CoV-2-related ischemic stroke.
Pardo K, Harnof O, Barnea R, Naftali J, Kenan G, Auriel E
PLoS One. 2024; 19(10):e0311622.
PMID: 39453913
PMC: 11508162.
DOI: 10.1371/journal.pone.0311622.
High prevalence of long COVID in anti-TPO positive euthyroid individuals with strongly elevated SARS-CoV-2-specific T cell responses and moderately raised anti-spike IgG levels 23 months post-infection.
Matula Z, Kiraly V, Beko G, Gonczi M, Zoka A, Steinhauser R
Front Immunol. 2024; 15:1448659.
PMID: 39450181
PMC: 11499158.
DOI: 10.3389/fimmu.2024.1448659.
Mechanisms of long COVID and the path toward therapeutics.
Peluso M, Deeks S
Cell. 2024; 187(20):5500-5529.
PMID: 39326415
PMC: 11455603.
DOI: 10.1016/j.cell.2024.07.054.
Prediction of Stroke After the COVID-19 Infection.
Babaee M, Atashgar K, Harandi A, Yousefi A
Basic Clin Neurosci. 2024; 15(1):89-100.
PMID: 39291093
PMC: 11403102.
DOI: 10.32598/bcn.2022.3608.1.
Is lupus anticoagulant testing with dilute Russell's viper venom clotting times reliable in the presence of inflammation?.
Hardy M, Catry E, Pouplard M, Lecompte T, Mullier F
Res Pract Thromb Haemost. 2024; 8(6):102536.
PMID: 39290988
PMC: 11406037.
DOI: 10.1016/j.rpth.2024.102536.
Effect of vitamin D on antiphospholipid antibodies in hospitalized patients with moderate to severe COVID-19.
Sales L, Souza L, Fernandes A, Murai I, Santos M, Vendramini M
Clinics (Sao Paulo). 2024; 79:100474.
PMID: 39208655
PMC: 11399608.
DOI: 10.1016/j.clinsp.2024.100474.
The Influence of SARS-CoV-2 Infection on the Development of Selected Neurological Diseases.
Krynska K, Kulis K, Mazurek W, Gudowska-Sawczuk M, Zajkowska M, Mroczko B
Int J Mol Sci. 2024; 25(16).
PMID: 39201402
PMC: 11354773.
DOI: 10.3390/ijms25168715.
Comparison of anti-phospholipid antibody titers before and after SARS-CoV-2 mRNA vaccination in hospital staff.
Hisano M, Morisaki N, Sampei M, Obikane E, Yamaguchi K
Vaccine X. 2024; 20:100539.
PMID: 39189026
PMC: 11345390.
DOI: 10.1016/j.jvacx.2024.100539.
